by Sophie Paczesny
Sophie Paczesny, MD, PhD, highlights her work advancing GVHD biomarker research and immunotherapy innovation while sharing her priorities as ASTCT board director of laboratory science. She also...
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Nirali Shah is joined by Dr. Christy Duncan and Dr. Sung‑Yun Pai to talk through recent progress in the field and what it actually takes to deliver these...
by Zahra Mahmoudjafari
Explore expert insights from ASTCT on building scalable, safe CGT (cell and gene therapy) programs, including key infrastructure, operational strategies, and sustainability considerations. This...
by Alex Kadhim
In a nationwide, retrospective cohort study, researchers from St. Mary’s Hospital, Kurume, and a nationwide consortium of Japanese transplant centers have shown that mycophenolate mofetil...
by Alex Kadhim
A recent single-center retrospective study, published in Transplantation and Cellular Therapy, investigated post-transplant outcomes in patients with TP53-mutated or 17p-deleted myeloid...
by Alex Kadhim
Researchers from the Hackensack University Medical Center have demonstrated that EZH2, a chromatin-modifying epigenetic enzyme, promotes alloreactive T cell survival during graft-versus-host...